La cadena de opciones muestra datos clave de las opciones de acciones de Inventiva a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Inventiva..

Inventiva (NASDAQ:IVA) Bolsa, Cadena de Opciones

Inventiva

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Inventiva S.A. - American Depository Shares

Inventiva SA

Intevac Inc

Alpha Architect International Quantitative Value ETF

Ivanhoe Electric Inc

IVANHOE MINES LTD A by Ivanhoe Mines Ltd.

Ivanhoe Mines Ltd

WIIM

Avino Silver & Gold Mines shares are trading higher after HC Wainwright & Co. raised its price target on the stock from $1.9 to $2.2.

Small Cap Consumer Research analyst Eric Beder maintains Vera Bradley (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRA#NASDAQ">VRA</a>) with a Buy and lowers the price target from $5.5 to $4.

News

Price Target

Analyst Ratings

Small Cap Consumer Research Maintains Buy on Vera Bradley, Lowers Price Target to $4

On Wednesday, Merck&nbsp;&amp; Co Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>) announced the presentation of results from two Phase 3 trials of doravirine/islatravir (DOR/ISL) in adults with HIV-1 infection that is virologically suppressed on bictegravir/emtricitabine/tenofovir alafenamidei&nbsp;(BIC/FTC/TAF) in trial&nbsp;MK-8591A-052) or antiretroviral therapy (bART) <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">in trial&nbsp;MK-8591A-051</a>.
In both trials, DOR/ISL met the primary efficacy success criterion for non-inferiority to comparator antiretroviral therapies and primary safety <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/b44280630/merck-announces-positive-data-from-phase-3-trials-that-show-the-investigational-once-daily-oral-tw" rel="noreferrer noopener">objectives at Week 48</a>.
The company released the topline data from both studies <a target="_blank" href="https://www.benzinga.com/general/biotech/24/12/42600482/mercks-investigational-two-drug-regime-for-hiv-meets-primary-goal-in-two-late-stage-trials" rel="noreferrer noopener">in December 2024</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/03/44252770/merck-injects-1-billion-to-expand-vaccine-production-in-us" rel="noreferrer noopener">Merck Injects $1 Billion To Expand Vaccine Production In US</a>
Merck plans to begin submitting applications for marketing authorization to regulatory agencies by mid-2025.
<ul>
<li>In the trial MK-8591A-052, results for the primary endpoint (HIV-1 RNA ≥50 copies/mL) showed that 1.5% of participants who switched to DOR/ISL had a viral load of ≥50 copies/mL at Week 48, compared to 0.6% on BIC/FTC/TAF.</li>
<li>At Week 48, 91.5% of participants who switched to DOR/ISL maintained viral suppression (HIV-1 RNA &lt;50 copies/mL) compared to 94.2% of participants who continued receiving BIC/FTC/TAF.</li>
</ul>
In the trial MK-8591A-051, results for the primary endpoint showed that 1.4% of participants who received DOR/ISL had a viral load of ≥50 copies/mL at Week 48, compared to 4.9% on bART.
<ul>
<li>At Week 48, 95.6% of participants who switched to DOR/ISL maintained viral suppression (HIV-1 RNA &lt;50 copies/mL) compared to 91.9% of participants who continued on bART.</li>
</ul>
Price Action: MRK stock is down 0.65% at $94.11 at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44281844/arcos-dorados-q4-earnings-beat-estimates-stock-gains" target="_blank" rel="noreferrer noopener">Arcos Dorados Q4 Earnings: Sales Slip, EPS Beat, South Latin America Strength And More</a></li>
</ul>
Photo Courtesy of Merck

Biotech

Large Cap

Health Care

General

Merck Plans Regulatory Submission For Two-Drug Regime For HIV Infection By Mid-2025

Howmet Aerospace's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HWM#NYSE">HWM</a>) short percent of float has risen 5.58% since its last report. The company recently reported that it has 9.44 million shares sold short, which is 2.65% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.96 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Howmet Aerospace Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741800628_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Howmet Aerospace has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Howmet Aerospace's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Howmet Aerospace's peer group average for short interest as a percentage of float is 3.82%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

What Does the Market Think About Howmet Aerospace?

Xcel Energy's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XEL#NYSE">XEL</a>) short percent of float has risen 12.35% since its last report. The company recently reported that it has 9.14 million shares sold short, which is 1.82% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.59 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Xcel Energy Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741800622_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Xcel Energy has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Xcel Energy's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Xcel Energy's peer group average for short interest as a percentage of float is 2.27%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Xcel Energy?

Essential Properties's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPRT#NYSE">EPRT</a>) short percent of float has risen 3.03% since its last report. The company recently reported that it has 13.42 million shares sold short, which is 10.19% of all regular shares that are available for trading. Based on its trading volume, it would take traders 8.8 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Essential Properties Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741800617_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Essential Properties has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Essential Properties's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Essential Properties's peer group average for short interest as a percentage of float is 2.30%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

EPRT

What Does the Market Think About Essential Properties?

A Reddit user recently shared a painful lesson in investing: convincing their parents to buy U.S. stocks just before the market took a sharp downturn. In a <a href="https://www.reddit.com/r/stocks/comments/1j840om/i_told_my_parents_to_buy_near_peak_and_now_i_feel/">post</a> that quickly gained traction on the&nbsp; r/stocks subreddit, the user admitted, &#8220;I've been telling my Asian parents to buy US stocks for about two years now. They finally caved in three weeks ago and bought 200,000 worth of SPY (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and 100,000 of Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>). And voila, the market collapsed.&#8221;
Feeling &#8220;like a clown,&#8221; the user lamented their timing and wondered if they should have advised waiting, especially with recent tariff concerns.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/qnetic-2">This 12,000 RPM Spinning Battery With Over $100 Million In LOIs Could Be The Missing Link For Green Energy — Here&#8217;s Why Early Investors Are Flocking To Invest Before Funding Closes</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
<h2 class="wp-block-heading">Reddit Responds</h2>
Responses to the post were overwhelming, and the most popular advice was brutally straightforward: &#8220;Never ever give <a href="https://www.benzinga.com/news/25/03/44219702/shaquille-oneal-tells-the-most-eye-opening-investment-advice-he-ever-got-and-it-was-from-an-80-year-old-he-taught-me-a-word-i-never-heard">investment advice</a>. You get no credit for the gains, and all the blame for the losses.&#8221; Another user reinforced this sentiment, pointing out the danger of stock-picking: &#8220;And don't give stupid advice like to put 1/3 of the portfolio in a single stock.&#8221;
A lot of people said it's important to <a href="https://www.benzinga.com/money/how-to-diversify-your-portfolio">spread out investments</a> instead of putting too much into one stock. One person explained that SPY was already a solid choice, but putting a big chunk into Nvidia was too risky since SPY already included some Nvidia shares.
Trending: <a href="https://www.benzinga.com/money/overplay">Mark Cuban Backs This Innovative Startup That Turns Videos into Games&nbsp; &#8212; Claim Your Share Now</a>
<h2 class="wp-block-heading">The Danger of Timing the Market</h2>
While some tried to reassure the original poster that <a href="https://www.benzinga.com/25/03/44171147/spy-etf-has-ruled-for-decades-but-is-it-still-the-best-bet">SPY is a long-term play</a> that will likely recover, others highlighted the emotional toll of investing at the wrong time. One commenter reflected, &#8220;I'm realizing it's not a good idea to influence people to buy stocks because when they go down, it's on you.&#8221;
Others emphasized that buying at market highs is a common mistake, with one user sarcastically stating, &#8220;So this is the real sentiment gauge, I guess. Sell when Asian parents are finally FOMO'ing.&#8221;
<h2 class="wp-block-heading">The Psychology of Investing</h2>
Beyond financial strategy, some users touched on the emotional impact of losing money. One wisely noted, &#8220;This is why I&#8217;ll always [dollar-cost averaging] instead of lump sum. Mental health is one of the biggest factors in investing. DCA&nbsp; keeps me in a better headspace and looking at things rationally.&#8221; DCA, involves spreading out purchases over time to reduce the risk of buying at a market peak.
See Also: <a href="https://www.benzinga.com/money/startengine-own">The $1.3 Billion Startup Investment Boom: How This Company's Explosive Growth Is Opening Doors For Everyday Investors With A New $500 Minimum</a>
Another highlighted the challenges of giving financial advice, saying, &#8220;I gave relatives advice on buying [A]mazon [(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amzn#NASDAQ">AMZN</a>)] years ago, after a triple in value, I told them to sell, which they did. The comment I got was, &#8216;Well, you bought way more than me, so you&#8217;re way better off than me now.&#8217; I mean, you&#8217;ll never get a thank you even when you give them a winning lotto ticket.&#8221;
<h2 class="wp-block-heading">A Lesson Learned</h2>
The original poster later clarified that their parents had insisted on picking a stock themselves, admitting, &#8220;I should have put my foot down and said no or at least diversified that across a number of stocks instead of one.&#8221;
Read Next:
<ul>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>

AMZN

NVDA

'I Feel Like A Clown Right Now'—Redditor Regrets Convincing Their Parents To Buy SPY And Nvidia Near The Peak, Just Before The Crash

MUFG

SMFG

Shares of US-listed Japanese banking companies are trading higher on weaker US economic data. The Bank of Japan may raise interest rates in response to February's PPI data to reach the country's 2% inflation target.

Needham analyst Ryan MacDonald reiterates Udemy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UDMY#NASDAQ">UDMY</a>) with a Buy and maintains $11 price target.

Reiteration

UDMY

Needham Reiterates Buy on Udemy, Maintains $11 Price Target

HC Wainwright &amp; Co. analyst Heiko Ihle maintains Avino Silver &amp; Gold Mines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ASM#AMEX">ASM</a>) with a Buy and raises the price target from $1.9 to $2.2.

HC Wainwright & Co. Maintains Buy on Avino Silver & Gold Mines, Raises Price Target to $2.2

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>B. Riley Securities cut Ciena Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) price target from $97 to $89. B. Riley Securities analyst Dave Kang maintained a Buy rating. Ciena shares closed at $63.95 on Tuesday. See how other analysts <a href="https://www.benzinga.com/quote/CIEN/analyst-ratings">view this stock</a>.</li>
<li>Truist Securities boosted the price target for Expedia Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>) from $163 to $175. Truist Securities analyst Greg Miller maintained a Hold rating. Expedia shares closed at $163.75 on Tuesday. <a href="https://www.benzinga.com/quote/EXPE/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan cut Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) price target from $135 to $120. JP Morgan analyst Ryan Brinkman maintained an Underweight rating. Tesla shares closed at $230.58 on Tuesday. See how other analysts <a href="https://www.benzinga.com/quote/TSLA/analyst-ratings">view this stock</a>.</li>
<li>Raymond James slashed the price target for Diamondback Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANG#NASDAQ">FANG</a>) from $245 to $214. Raymond James analyst John Freeman maintained a Strong Buy rating. Diamondback Energy shares closed at $144.65 on Tuesday. <a href="https://www.benzinga.com/quote/FANG/analyst-ratings">See how other analysts view this stock.</a></li>
<li>DA Davidson cut the price target for RumbleOn, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBL#NASDAQ">RMBL</a>) from $5 to $4. DA Davidson analyst Michael Baker maintained a Neutral rating. RumbleOn shares closed at $3.59 on Tuesday. See how other analysts view<a href="https://www.benzinga.com/quote/RMBL/analyst-ratings"> this stock</a>.</li>
<li>Susquehanna cut Teradyne, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) price target from $165 to $155. Susquehanna analyst Mehdi Hosseini maintained a Positive rating. Teradyne shares settled at $87.07 on Tuesday. <a href="https://www.benzinga.com/quote/TER/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>RBC Capital slashed Illumina, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>) price target from $247 to $128. RBC Capital analyst Conor McNamara maintained an Outperform rating. Illumina shares closed at $84.52 on Tuesday. <a href="https://www.benzinga.com/quote/ILMN/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Macquarie cut Vail Resorts, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTN#NYSE">MTN</a>) price target from $195 to $185. Macquarie analyst Paul Golding maintained a Neutral rating. Vail Resorts shares closed at $165.42 on Tuesday.  <a href="https://www.benzinga.com/quote/MTN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wedbush cut the price target for Arvinas, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARVN#NASDAQ">ARVN</a>) from $57 to $12. Wedbush analyst Robert Driscoll downgraded the stock from Outperform to Neutral. Arvinas shares settled at $8.30 on Tuesday. <a href="https://www.benzinga.com/quote/ARVN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup raised Core Laboratories Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLB#NYSE">CLB</a>) price target from $15 to $16. Citigroup analyst Scott Gruber upgraded the stock from Sell to Neutral. Core Laboratories shares closed at $14.62 on Tuesday. <a href="https://www.benzinga.com/quote/clb/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44274110/top-2-industrials-stocks-that-may-collapse-in-march">Top 2 Industrials Stocks That May Collapse In March</a></li>
</ul>

Markets

ARVN

CIEN

EXPE

FANG

ILMN

RMBL

TSLA

Tesla To $120? Here Are 10 Top Analyst Forecasts For Wednesday

Tilray Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares are<a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/g44271683/tilray-grows-its-non-alcoholic-craft-beer-line-runners-high-brewing-across-the-east-coast-and-mid-" rel="noreferrer noopener"> trading nearly flat on Wednesday.</a>
The company&#8217;s stock is rising following two significant announcements today and yesterday. On Wednesday, the company revealed a significant expansion for Runner&#8217;s High Brewing, its non-alcoholic craft beer brand, which will now be available at 4,500 new distribution points.
This includes major retailers such as Publix, HEB, Harris Teeter, and Lowes Foods.
With this expansion, Tilray aims to make Runner&#8217;s High a go-to beverage for runners and beer lovers alike.
The brand offers three varieties: Golden Wheat, Raspberry Wheat, and Dark Chocolate, each low in calories and designed to appeal to health-conscious consumers.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/management/25/03/44282015/cannabis-firm-cresco-labs-reports-mixed-q4-ceo-says-company-will-strategically-deploy-capital-to-create-growth-in-2025" rel="noreferrer noopener">Cannabis Firm Cresco Labs Reports Mixed Q4, CEO Says Company Will &#8216;Strategically Deploy Capital To Create Growth&#8217; In 2025</a>
Additionally, Runner&#8217;s High is reinforcing its position in the running community through a partnership with the Atlanta Track Club and participation in the world-renowned Peachtree Road Race this July.
In another move, Tilray introduced Tilray Craft yesterday, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/g44242769/tilray-medical-launches-tilray-craft-introducing-high-thc-high-terpene-genetics-to-the-german-medi" rel="noreferrer noopener">a new extension of its medical cannabis portfolio.</a>
This brand, launched in Germany, will provide flower-based cannabis products with higher THC and terpene content for patients.
The latest product under the Tilray Craft brand is Cannabisblüten THC 25 TAM, a sativa-leaning hybrid strain.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, TLRY stock has lost over 63% in the past year. Investors can gain exposure to the stock via&nbsp;Amplify ETF Trust Amplify Alternative Harvest ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MJ#NYSE">MJ</a>) and AdvisorShares Pure Cannabis ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YOLO#NYSE">YOLO</a>).
Price Action: TLRY shares are trading lower by 0.22% to $0.6083 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44270724/rocket-lab-takes-a-bold-leap-75-million-offer-for-mynaric-to-boost-satellite-tech-sda-contracts" target="_blank" rel="noreferrer noopener">Rocket Lab Expands Its Space Arsenal: Eyes Laser Tech Boost With Mynaric Buyout</a></li>
</ul>
Image Source: Tilray Brands, Inc..

Cannabis

Equities

Movers

TLRY

YOLO

What's Going On With Cannabis Firm Tilray Brands Stock On Wednesday?

President Donald Trump's tariff plans for Mexico and Canada could have a dramatic impact on the automotive sector, with reports that vehicles could rise in price by up to <a href="https://www.benzinga.com/25/03/44119668/trump-tariffs-could-make-your-next-car-12000-more-expensive-expert-says-25-fees-will-have-a-sharp-negative-effect-on-auto-sales">$12,000 for consumers.</a>
Trump recently paused a tariff on the auto sector for Mexico and Canada, prompting Benzinga to ask readers if they support the decision and if it makes them more likely to buy a vehicle before tariffs come back.
 What Happened: A short-lived tariff of 25% on imported goods from Mexico and Canada against the automotive sector was <a href="https://www.benzinga.com/25/03/44149833/trump-delays-ford-gm-stellantis-from-from-tariffs-on-mexico-canada-for-one-month">paused by Trump</a> with plans to come back in April.
The tariff is expected to hurt automotive companies such as Ford Motor Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>), General Motors Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) and Stellantis NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>), which have models assembled in Mexico and Canada.
Auto companies will likely be forced with decisions of moving production to America where wages are higher or paying higher tariffs on imported items. Either way, vehicles will likely be more expensive to make and the higher costs could be passed on to consumers.
Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) assembles its vehicles in America and will have a <a href="https://www.benzinga.com/25/03/44176616/trump-vs-musk-tesla-to-be-hurt-by-tariffs-on-mexico-despite-friendship">lower impact from</a> the tariffs, but the EV maker imports auto parts from Mexico that could impact its costs as well.
Benzinga recently asked readers how they feel about the tariff decisions.
"Do you support President Trump's decision to grant a one-month tariff exemption for automakers?" Benzinga asked.
The results were:
<ul>
<li>Yes: 75%</li>
<li>No: 25%</li>
</ul>
The majority of readers support the tariff pause to April with 75% saying yes.
"Would you consider buying a vehicle before President Trump's auto tariff exemption expires?" Benzinga asked.
The results were:
<ul>
<li>Yes: 28%</li>
<li>No: 72%</li>
</ul>
The poll found the majority of readers won't be rushing out to buy a vehicle ahead of the potential canceling of the pause of the tariff exemption planned for April.
This result comes as Trump's tariff plans have been sporadic in nature of being imposed, enforced and lasting for more than a day or several days.
Read Also: <a href="https://www.benzinga.com/news/econ-s/25/03/44262286/tariff-uncertainty-poses-major-risk-to-us-automakers-how-much-could-ford-gm-earnings-fall">Tariff Uncertainty Poses Major Risk To US Automakers: How Much Could Ford, GM Earnings Fall?</a>
Why It's Important: Consumers will likely be hurt by tariffs on various goods across multiple sectors depending on the timing and length of the tariffs.
Automobiles are one of the larger industries to be impacted, but many people wait to buy a vehicle for several years as it is a major cost. With higher prices for automobiles, consumers could put off buying a new vehicle until tariff concerns go away, if at all.
The poll finds people support the tariff exemption for the auto sector, but it doesn't mean they will buy a new vehicle.
<a href="https://www.benzinga.com/trading-ideas/25/02/43827291/exclusive-will-trumps-tariffs-hurt-or-help-stock-market-59-say-this">Benzinga recently asked</a> if the tariffs could impact stock market indexes like the S&amp;P 500, which is tracked by the&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>).
&#8220;How will Trump&#8217;s tariffs affect the stock market?&#8221; Benzinga asked.
The results were:
<ul>
<li>Weigh down: 59%</li>
<li>Push higher: 23%</li>
<li>No real impact: 19%</li>
</ul>
The majority of respondents said Trump&#8217;s tariffs will send the stock market lower. The remaining voters were split nearly even between the stock market going higher as the result of tariffs or the tariffs not having a real impact on stock market returns.
That poll was conducted Feb. 11 and Feb. 12. Since Feb. 12, the SPDR S&amp;P 500 ETF Trust is down 7.5% with tariffs a large factor likely weighing the S&amp;P 500 Index down and proving Benzinga readers were right.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/01/43041374/exclusive-how-high-will-sp-500-go-under-donald-trump-in-2025-readers-are-optimistic-26-say-this">EXCLUSIVE: How High Will S&amp;P 500 Go Under Donald Trump In 2025? Readers Are Optimistic, 26% Say This…</a></li>
</ul>
The first two questions/study were conducted by Benzinga from March 6, 2025, through March 7, 2025. It included the responses of a diverse population of adults 18 or older. Opting into the survey was completely voluntary, with no incentives offered to potential respondents. The study reflects results from 192 adults.
Photos: Shutterstock

Politics

Exclusives

STLA

Trump Tariff Delay On Autos Supported By 75% Of Readers In Poll: Will Pause Lead To More Purchases Ahead Of April?

Kohl&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) shares are trading lower on Wednesday. The stock may be moving on continued weakness after the company reported fourth-quarter financial results and issued <a href="https://www.benzinga.com//node/44262764">guidance on Tuesday</a>.
What To Know: Kohl&#8217;s issued guidance for fiscal-year 2025, projecting a 5% to 7% decline in net sales and a 4% to 6% drop in comparable sales. The company cited &#8220;constrained&#8221; shoppers as one reason for the anticipated drop in net sales. 
If you&#8217;re making less than 50 [thousand], that consumer is pretty constrained from a discretionary standpoint. If you&#8217;re making less than 100 [thousand], it&#8217;s also pretty challenging. And you see that very clearly in numbers,&#8221;&nbsp;said Kohl&#8217;s CEO Ashley Buchanan.
The CEO also noted that consumers are increasingly seeking better value in their purchases.
According to <a href="https://www.benzinga.com/news/econ-s/25/02/43736972/us-retail-sales-fall-more-than-expected-raise-growth-concerns">Commerce Department data</a>, retail sales fell 0.9% across the U.S. in January, missing economist expectations of a 0.2% decline. A Bureau of Labor Statistics <a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44274165/inflation-cools-more-than-expected-in-february-strengthens-the-case-for-fed-rate-cuts">report indicates inflation</a> eased in February, though rising shelter costs may continue to pressure low-income consumers.
Analyst Changes: Following the earnings report, multiple analysts cut their price targets.
<ul>
<li>Baird analyst Mark Altschwager maintained a Neutral rating on Kohl&#8217;s and lowered the price target from&nbsp;$18&nbsp;to&nbsp;$11.</li>
<li>B of A Securities analyst Lorraine Hutchinson maintained an Underperform rating on Kohl&#8217;s and lowered the price target from&nbsp;$15&nbsp;to&nbsp;$8.</li>
<li>Morgan Stanley analyst Kimberly Greenberger maintained an Underweight rating on Kohl&#8217;s and lowered the price target from&nbsp;$10&nbsp;to&nbsp;$8.</li>
<li>Telsey Advisory Group analyst Dana Telsey maintained a Market Perform rating on Kohl&#8217;s and lowered the price target from&nbsp;$13&nbsp;to&nbsp;$10.</li>
</ul>
See Also: <a href="https://www.benzinga.com/general/restaurants/25/03/44280041/rfk-jr-thanks-steak-n-shake-for-rfking-the-french-fries-restaurant-goes-all-in-on-make-america-healthy-again">RFK Jr Thanks Steak &#8216;N Shake For &#8216;RFKing The French Fries&#8217;: Restaurant Goes All In On Make America Healthy Again</a>
KSS Price Action: At the time of publication, Kohl&#8217;s stock is trading 6.72% lower at $8.53, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: via Shutterstock

What's Going On With Kohl's Stock Wednesday?

Oil is trading higher after Canada's Energy Minister threatened to restrict crude oil exports to the US over tariffs. Also, oil is trading higher following a draw in US crude oil inventories.

<h3>Gainers</h3>
<ul>
<li>E W Scripps (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSP#NASDAQ">SSP</a>) stock increased by 28.7% to $1.84 during Wednesday's regular session. The company's market cap stands at $158.9 million. The company's, Q4 earnings came out yesterday. </li>
<li>CuriosityStream (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURI#NASDAQ">CURI</a>) shares rose 21.8% to $2.57. The company's market cap stands at $142.5 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>LQR House (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YHC#NASDAQ">YHC</a>) shares moved upwards by 18.75% to $1.9. The market value of their outstanding shares is at $43.0 million. </li>
<li>QMMM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QMMM#NASDAQ">QMMM</a>) shares increased by 15.06% to $1.68. The market value of their outstanding shares is at $28.9 million. </li>
<li>iClick Interactive Asia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLK#NASDAQ">ICLK</a>) stock rose 13.61% to $9.54. The market value of their outstanding shares is at $84.7 million. </li>
<li>AirNet Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANTE#NASDAQ">ANTE</a>) shares rose 13.1% to $0.47. The company's market cap stands at $6.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>GDEV (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDEV#NASDAQ">GDEV</a>) shares fell 16.6% to $16.02 during Wednesday's regular session. The company's market cap stands at $290.0 million. </li>
<li>Starbox Group Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STBX#NASDAQ">STBX</a>) shares fell 14.58% to $0.29. The market value of their outstanding shares is at $2.1 million. </li>
<li>Lytus Technologies Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYT#NASDAQ">LYT</a>) shares decreased by 14.12% to $0.15. The company's market cap stands at $3.5 million. </li>
<li>Direct Digital Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRCT#NASDAQ">DRCT</a>) shares declined by 12.27% to $0.83. The company's market cap stands at $14.3 million. </li>
<li>LZ Technology Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LZMH#NASDAQ">LZMH</a>) shares declined by 12.26% to $7.02. The market value of their outstanding shares is at $1.0 billion. </li>
<li>VS Media Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSME#NASDAQ">VSME</a>) shares fell 10.66% to $0.87. The company's market cap stands at $3.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ANTE

CURI

DRCT

GDEV

ICLK

LZMH

QMMM

STBX

VSME

12 Communication Services Stocks Moving In Wednesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>CervoMed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRVO#NASDAQ">CRVO</a>) stock increased by 151.1% to $5.93 during Wednesday's regular session. The market value of their outstanding shares is at $48.9 million. </li>
<li>OptimizeRx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPRX#NASDAQ">OPRX</a>) shares rose 35.74% to $5.62. The company's market cap stands at $103.5 million. As per the press release, Q4 earnings came out today. </li>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) shares increased by 26.86% to $0.41. The market value of their outstanding shares is at $2.6 million. </li>
<li>HeartSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSCS#NASDAQ">HSCS</a>) stock increased by 19.86% to $3.5. The market value of their outstanding shares is at $3.4 million. </li>
<li>Baird Medical Investment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDMD#NASDAQ">BDMD</a>) stock rose 18.18% to $5.46. The market value of their outstanding shares is at $198.5 million. </li>
<li>Shuttle Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHPH#NASDAQ">SHPH</a>) shares moved upwards by 18.18% to $0.5. The market value of their outstanding shares is at $2.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Zynex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYXI#NASDAQ">ZYXI</a>) stock fell 53.9% to $3.23 during Wednesday's regular session. The market value of their outstanding shares is at $102.8 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Hepion Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEPA#NASDAQ">HEPA</a>) shares decreased by 40.6% to $0.05. </li>
<li>Syros Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRS#NASDAQ">SYRS</a>) stock decreased by 30.23% to $0.09. The company's market cap stands at $2.5 million. </li>
<li>Impact BioMedical (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IBO#AMEX">IBO</a>) stock declined by 29.42% to $0.6. The company's market cap stands at $6.9 million. </li>
<li>Tenon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNON#NASDAQ">TNON</a>) shares fell 25.24% to $1.13. The market value of their outstanding shares is at $3.5 million. </li>
<li>Cutera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CUTR#NASDAQ">CUTR</a>) shares declined by 18.54% to $0.09. The market value of their outstanding shares is at $1.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BDMD

CRVO

CUTR

HCTI

HEPA

HSCS

OPRX

SHPH

SYRS

TNON

ZYXI

12 Health Care Stocks Moving In Wednesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Vast Renewables (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTE#NASDAQ">VSTE</a>) stock increased by 52.5% to $0.76 during Wednesday's regular session. The market value of their outstanding shares is at $22.8 million. </li>
<li>Solidion Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STI#NASDAQ">STI</a>) stock moved upwards by 37.35% to $0.17. The company's market cap stands at $22.9 million. </li>
<li>Satellogic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATL#NASDAQ">SATL</a>) shares increased by 29.55% to $3.82. The company's market cap stands at $369.2 million. </li>
<li>Nuburu (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BURU#AMEX">BURU</a>) shares moved upwards by 25.94% to $0.21. The company's market cap stands at $4.3 million. </li>
<li>American Rebel Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AREB#NASDAQ">AREB</a>) shares rose 22.5% to $0.37. </li>
<li>High-Trend International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTCO#NASDAQ">HTCO</a>) stock increased by 21.98% to $1.72. The market value of their outstanding shares is at $95.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Armlogi Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTOC#NASDAQ">BTOC</a>) stock fell 14.2% to $1.27 during Wednesday's regular session. The company's market cap stands at $52.9 million. </li>
<li>Concrete Pumping Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBCP#NASDAQ">BBCP</a>) stock decreased by 13.75% to $5.21. The market value of their outstanding shares is at $276.1 million. The company's, Q1 earnings came out yesterday. </li>
<li>Icon Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICON#NASDAQ">ICON</a>) stock decreased by 13.66% to $0.1. The company's market cap stands at $2.8 million. </li>
<li>Commercial Vehicle Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVGI#NASDAQ">CVGI</a>) shares declined by 10.34% to $1.6. The market value of their outstanding shares is at $55.3 million. The company's, Q4 earnings came out 2 days ago. </li>
<li>OceanPal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OP#NASDAQ">OP</a>) stock decreased by 10.11% to $0.89. The market value of their outstanding shares is at $6.6 million. </li>
<li>Captivision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPT#NASDAQ">CAPT</a>) shares fell 9.46% to $0.55. The market value of their outstanding shares is at $17.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AREB

BBCP

BTOC

BURU

CAPT

CVGI

HTCO

ICON

SATL

VSTE

12 Industrials Stocks Moving In Wednesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>ZenaTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZENA#NASDAQ">ZENA</a>) stock increased by 34.5% to $3.78 during Wednesday's regular session. The market value of their outstanding shares is at $66.7 million. </li>
<li>SatixFy Communications (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SATX#AMEX">SATX</a>) stock moved upwards by 28.44% to $1.49. The company's market cap stands at $124.5 million. </li>
<li>Synchronoss Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNCR#NASDAQ">SNCR</a>) stock moved upwards by 26.57% to $9.03. The market value of their outstanding shares is at $97.8 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Applied Optoelectronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAOI#NASDAQ">AAOI</a>) stock rose 20.23% to $18.12. The company's market cap stands at $903.3 million. </li>
<li>Sprinklr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CXM#NYSE">CXM</a>) stock moved upwards by 16.58% to $9.42. The market value of their outstanding shares is at $2.3 billion. As per the press release, Q4 earnings came out today. </li>
<li>IonQ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>) shares increased by 15.56% to $21.61. The market value of their outstanding shares is at $4.8 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Smith Micro Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMSI#NASDAQ">SMSI</a>) shares decreased by 41.4% to $0.63 during Wednesday's regular session. The market value of their outstanding shares is at $11.1 million. The company's, Q4 earnings came out yesterday. </li>
<li>Wellchange Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WCT#NASDAQ">WCT</a>) shares decreased by 29.23% to $0.51. The market value of their outstanding shares is at $23.4 million. </li>
<li>Auddia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) shares decreased by 11.39% to $0.28. The company's market cap stands at $1.5 million. </li>
<li>Ondas Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONDS#NASDAQ">ONDS</a>) stock decreased by 9.96% to $0.65. The company's market cap stands at $67.9 million. As per the news, the Q4 earnings report came out today. </li>
<li>MagnaChip Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MX#NYSE">MX</a>) shares fell 8.92% to $3.68. The company's market cap stands at $136.9 million. As per the press release, Q4 earnings came out today. </li>
<li>GDS Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDS#NASDAQ">GDS</a>) shares declined by 8.7% to $35.41. The company's market cap stands at $6.8 billion. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AAOI

AUUD

IONQ

ONDS

SatixFy Communications Ltd. Ordinary Share

SATX

SMSI

SNCR

ZENA

12 Information Technology Stocks Moving In Wednesday's Intraday Session

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Jefferies analyst Kaumil Gajrawala downgraded the rating for PepsiCo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) from Buy to Hold and lowered the price target from $171 to $170. PepsiCo shares closed at $152.33 on Tuesday. <a href="https://www.benzinga.com/quote/pep/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Ladenburg Thalmann analyst Jeffrey Cohen downgraded Zynex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYXI#NASDAQ">ZYXI</a>) from Buy to Neutral. Zynex shares closed at $7.00 on Tuesday. <a href="https://www.benzinga.com/quote/zyxi/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wedbush analyst Robert Driscoll downgraded Arvinas, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARVN#NASDAQ">ARVN</a>) from Outperform to Neutral and lowered the price target from $57 to $12. Arvinas shares closed at $8.30 on Tuesday. <a href="https://www.benzinga.com/quote/arvn/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS analyst Graham Doyle downgraded the rating for Smith &amp; Nephew plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNN#NYSE">SNN</a>) from Buy to Neutral. Smith &amp; Nephew shares closed at $29.84 on Tuesday. <a href="https://www.benzinga.com/quote/snn/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>William Blair analyst Maggie Nolan downgraded Magic Software Enterprises Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGIC#NASDAQ">MGIC</a>) from Outperform to Market Perform. Magic Software shares closed at $13.39 on Tuesday. <a href="https://www.benzinga.com/quote/mgic/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying PEP stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="602" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/12130446/image-88-1024x602.png" alt="" class="wp-image-821432" style="width:642px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/12130446/image-88-1024x602.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/12130446/image-88-300x176.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/12130446/image-88-768x451.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/12130446/image-88.png 1152w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44274110/top-2-industrials-stocks-that-may-collapse-in-march">Top 2 Industrials Stocks That May Collapse In March</a></li>
</ul>

Downgrades

MGIC

This PepsiCo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Press Releases

Inventiva reports 2024 Third Quarter Financial Information¹

Results of the votes of the Combined Shareholders' General Meeting of December 11, 2024

Inventiva secures €21.4 million and completes the first tranche of the previously announced multi-tranche financing  of up to €348 million

Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference

Results of LEGEND evaluating lanifibranor in combination with empagliflozin in MASH selected for oral presentation at the upcoming EASL SLD Summit 2025

Half-Year Review of Inventiva's Liquidity Contract with Kepler Cheuvreux

Inventiva announces the publication of the results from the investigator-initiated proof-of-concept clinical trial evaluating lanifibranor in patients with T2D and MASLD in the Journal of Hepatology

Inventiva reports preliminary 2024 fiscal year financial results¹ and provides a business update

Inventiva and Hepalys Pharma, Inc. announce the initiation of the clinical development program of lanifibranor in Japan with the dosing of the first participant in Phase 1 trial

Inventiva announces the publication in Biomedicine & Pharmacotherapy of the results from a preclinical study showing improvement of portal hypertension with lanifibranor treatment

Comments

Inventiva

Inventiva (IVA) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL